SCIENTURE REPORTS Q3 2026 RESULTS WITH APPROXIMATELY 265% SEQUENTIAL REVENUE GROWTH DRIVEN BY THE COMMERCIAL LAUNCH OF REZENOPY™

Reuters · 1d ago

Please log in to view news